Buthionine sulfoximine, an inhibitor of glutathione biosynthesis, induces expression of soluble epoxide hydrolase and markers of cellular hypertrophy in a rat cardiomyoblast cell line: Roles of the NF-κB and MAPK signaling pathways
- 1 May 2015
- journal article
- Published by Elsevier in Free Radical Biology and Medicine
- Vol. 82, 1-12
Abstract
No abstract availableKeywords
Funding Information
- Canadian Institutes of Health Research (CIHR) (MOP106665)
This publication has 60 references indexed in Scilit:
- Impact of Soluble Epoxide Hydrolase and Epoxyeicosanoids on Human HealthAnnual Review of Pharmacology and Toxicology, 2013
- Epoxides and Soluble Epoxide Hydrolase in Cardiovascular PhysiologyPhysiological Reviews, 2012
- Soluble epoxide hydrolase inhibition, epoxygenated fatty acids and nociceptionProstaglandins & Other Lipid Mediators, 2011
- Soluble epoxide hydrolase as a therapeutic target for cardiovascular diseasesNature Reviews Drug Discovery, 2009
- Transcriptional regulation of the human soluble epoxide hydrolase gene EPHX2Biochimica et Biophysica Acta (BBA) - Gene Regulatory Mechanisms, 2008
- Action of epoxyeicosatrienoic acids on cellular functionAmerican Journal of Physiology-Cell Physiology, 2007
- Hipertrofia cardiaca: eventos moleculares y celularesRevista Espanola de Cardiologia, 2006
- Increased left ventricular mass is a risk factor for the development of a depressed left ventricular ejection fraction within five yearsJACC, 2004
- Long-Term Trends in the Incidence of and Survival with Heart FailureNew England Journal of Medicine, 2002
- Prognostic Significance of Serial Changes in Left Ventricular Mass in Essential HypertensionCirculation, 1998